Stockreport

Ventyx Provides Clinical and Corporate Updates

Ventyx Biosciences, Inc.  (VTYX) 
PDF Strengthening our Advisory Board with addition of Mark McKenna as Strategic Advisor and Peter Libby, MD as a Clinical AdvisorExpanding the Phase 2 recurrent pericarditis [Read more]